| Year |
Title |
Altmetric |
| 2020
|
Selective Response to Bacterial Infection by Regulating Siglec-E Expression.
iScience.
23.
2020
|
|
| 2020
|
Fibrinogen alpha chain knockout promotes tumor growth and metastasis through integrin-akt signaling pathway in lung cancer.
Molecular Cancer Research.
18:943-954.
2020
|
|
| 2020
|
A CD24-p53 axis contributes to African American prostate cancer disparities
2020
|
|
| 2019
|
MicroRNA-1205, encoded on chromosome 8q24, targets EGLN3 to induce cell growth and contributes to risk of castration-resistant prostate cancer.
Oncogene.
38:4820-4834.
2019
|
|
| 2019
|
Loss of FOXP3 and TSC1 accelerates prostate cancer progression through synergistic transcriptional and posttranslational regulation of c-Myc.
Cancer Research.
79:1413-1425.
2019
|
|
| 2018
|
Bioprocess development of antibody-drug conjugate production for cancer treatment.
PLoS One.
13.
2018
|
|
| 2018
|
FOXP3 activates SUMO-conjugating UBC9 gene in MCF7 breast cancer cells.
International Journal of Molecular Sciences.
19.
2018
|
|
| 2018
|
Integrated oncogenomic profiling of copy numbers and gene expression in lung adenocarcinomas without EGFR mutations or ALK fusion.
Journal of Cancer.
9:1096-1105.
2018
|
|
| 2017
|
MicroRNA-200c and microRNA- 141 are regulated by a FOXP3-KAT2B axis and associated with tumor metastasis in breast cancer.
Breast Cancer Research.
19.
2017
|
|
| 2017
|
CD24 is a genetic modifier for risk and progression of prostate cancer.
Molecular Carcinogenesis.
56:641-650.
2017
|
|
| 2017
|
MicroRNA-155, induced by FOXP3 through transcriptional repression of BRCA1, is associated with tumor initiation in human breast cancer.
Oncotarget.
8:41451-41464.
2017
|
|
| 2016
|
Sema6D acts downstream of bone morphogenetic protein signalling to promote atrioventricular cushion development in mice.
Cardioscience.
112:532-542.
2016
|
|
| 2016
|
Sema6D acts downstream of bone morphogenetic protein signalling to promote atrioventricular cushion development in mice..
Cardiovascular Research.
112:532-542.
2016
|
|
| 2016
|
Cinobufagin inhibits tumor growth by inducing intrinsic apoptosis through AKT signaling pathway in human nonsmall cell lung cancer cells.
Oncotarget.
7:28935-28946.
2016
|
|
| 2016
|
Silencing of CD24 enhances the PRIMA-1-induced restoration of mutant p53 in prostate cancer cells.
Clinical Cancer Research.
22:2545-2554.
2016
|
|
| 2016
|
CD24 genetic variants contribute to overall survival in patients with gastric cancer.
World Journal of Gastroenterology.
22:2373-2382.
2016
|
|
| 2016
|
The Key Regulator for Language and Speech Development, FOXP2, is a Novel Substrate for SUMOylation.
Journal of Cellular Biochemistry.
117:426-438.
2016
|
|
| 2015
|
FOXP3 controls an MIR-146/NF-κB negative feedback loop that inhibits apoptosis in breast cancer cells.
Cancer Research.
75:1703-1713.
2015
|
|
| 2015
|
FOXP3-MIR-146-NF-κB axis and therapy for precancerous lesions in prostate.
Cancer Research.
75:1714-1724.
2015
|
|
| 2015
|
Intracellular CD24 disrupts the ARF-NPM interaction and enables mutational and viral oncogene-mediated p53 inactivation.
Nature Communications.
6.
2015
|
|
| 2015
|
FOXP3-microRNA-146-NF-κB as oncotarget.
Oncoscience.
2:839-840.
2015
|
|
| 2015
|
SEMA6D expression and patient survival in breast invasive carcinoma.
International Journal of Breast Cancer.
2015.
2015
|
|
| 2014
|
SUMOylation of FOXM1B alters its transcriptional activity on regulation of MiR-200 family and JNK1 in MCF7 human breast cancer cells.
International Journal of Molecular Sciences.
15:10233-10251.
2014
|
|
| 2014
|
The growth inhibitory effect of 17-DMAG on ALK and MYCN double-positive neuroblastoma cell line
2014
|
|
| 2013
|
Acidic residue Glu199 increases SUMOylation level of nuclear hormone receptor NR5A1.
International Journal of Molecular Sciences.
14:22331-22345.
2013
|
|
| 2013
|
IPEX Syndrome, FOXP3 and Cancer.
2013
|
|
| 2013
|
FOXP3 regulates sensitivity of cancer cells to irradiation by transcriptional repression of BRCA1.
Cancer Research.
73:2170-2180.
2013
|
|
| 2013
|
SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
Journal of Cellular Biochemistry.
114:589-598.
2013
|
|
| 2012
|
Inactivation of X-linked tumor suppressor genes in human cancer.
Future Oncology.
8:463-481.
2012
|
|
| 2012
|
A hypermorphic SP1-binding CD24 variant associates with risk and progression of multiple sclerosis.
American Journal of Translational Research.
4:347-356.
2012
|
|
| 2011
|
FOXP3 orchestrates H4K16 acetylation and H3K4 trimethylation for activation of multiple genes by recruiting MOF and causing displacement of PLU-1.
Molecular Cell.
44:770-784.
2011
|
|
| 2011
|
Identification of a tumor suppressor relay between the FOXP3 and the Hippo pathways in breast and prostate cancers.
Cancer Research.
71:2162-2171.
2011
|
|
| 2010
|
Association between hepatitis B viral burden in chronic infection and a functional single nucleotide polymorphism of the PDCD1 gene.
Journal of Clinical Immunology.
30:855-860.
2010
|
|
| 2010
|
Signalling through FOXP3 as an X-linked tumor suppressor.
2010
|
|
| 2010
|
Synergistic activation of the Mc2r promoter by FOXL2 and NR5A1 in mice.
Biology of Reproduction.
83:842-851.
2010
|
|
| 2010
|
X-linked tumor suppressors: Perplexing inheritance, a unique therapeutic opportunity.
Trends in Genetics.
26:260-265.
2010
|
|
| 2009
|
CD24 polymorphisms affect risk and progression of chronic hepatitis B virus infection.
Hepatology.
50:735-742.
2009
|
|
| 2009
|
Somatic Single Hits Inactivate the X-Linked Tumor Suppressor FOXP3 in the Prostate.
Cancer Cell.
16:336-346.
2009
|
|
| 2009
|
Targeting lymphotoxin-mediated negative selection to prevent prostate cancer in mice with genetic predisposition.
2009
|
|
| 2009
|
F0XP3 Up-regulates p21 expression by site-specific inhibition of histone deacetylase 2/histone deacetylase 4 association to the locus.
Cancer Research.
69:2252-2259.
2009
|
|
| 2008
|
Laforin negatively regulates cell cycle progression through glycogen synthase kinase 3β-dependent mechanisms.
Molecular and Cellular Biology.
28:7236-7244.
2008
|
|
| 2007
|
FOXP3 is a novel transcriptional repressor for the breast cancer oncogene SKP2.
Journal of Clinical Investigation.
117:3765-3773.
2007
|
|
| 2007
|
FOXP3 Is an X-Linked Breast Cancer Suppressor Gene and an Important Repressor of the HER-2/ErbB2 Oncogene.
Cell.
129:1275-1286.
2007
|
|
| 2007
|
A dinucleotide deletion in CD24 confers protection against autoimmune diseases.
PLoS Genetics.
3:0508-0517.
2007
|
|
| 2006
|
Impact of IGF-I and CYP19 gene polymorphisms on the survival of patients with metastatic prostate cancer.
Journal of Clinical Oncology.
24:1982-1989.
2006
|
|
| 2005
|
An A/G polymorphism of core 2 branching enzyme gene is associated with prostate cancer.
Biochemical and Biophysical Research Communications.
331:958-963.
2005
|
|
| 2005
|
CA repeat polymorphism in the insulin-like growth factor-I gene is associated with increased risk of prostate cancer and benign prostatic hyperplasia..
International Journal of Oncology.
26:225-231.
2005
|
|
| 2004
|
Serum sex steroid hormone levels and polymorphisms of CYP17 and SRD5A2: Implication for prostate cancer risk.
Prostate Cancer and Prostatic Diseases.
7:333-337.
2004
|
|
| 2004
|
Clinical characteristics of normotensive renal transplant recipients with microalbuminuria and effects of angiotensin II type I receptor antagonist on urinary albumin excretion.
International Journal of Urology.
11:585-591.
2004
|
|
| 2004
|
Polymorphism within the cyclin D1 gene is associated with an increased risk of carcinoma in situ in patients with superficial bladder cancer.
Urology.
64:74-78.
2004
|
|
| 2004
|
Increased risk of prostate cancer and benign prostatic hyperplasia associated with transforming growth factor-beta 1 gene polymorphism at codon10.
Carcinogenesis.
25:237-240.
2004
|
|
| 2004
|
Increased risk of bladder cancer associated with a glutathione peroxidase 1 codon 198 variant.
Investigative urology.
172:728-732.
2004
|
|
| 2003
|
Polymorphisms in prostate-specific antigen (PSA) gene, risk of prostate cancer, and serum PSA levels in Japanese population.
Cancer Letters.
202:53-59.
2003
|
|
| 2002
|
Single nucleotide polymorphisms in the 3′ untranslated region of vascular endothelial growth factor gene in Japanese population with or without renal cell carcinoma
2002
|
|
| 2002
|
Cyclin D1 gene polymorphism is associated with an increased risk of urinary bladder cancer.
Carcinogenesis.
23:257-264.
2002
|
|
